Improving brain function in adults with Type 2 diabetes using thiamine
Official title: Type 2 Diabetes Mellitus and Blood Brain Barrier Improvement - A Randomized Clinical Trial
Run by University of California, Los Angeles · NCT06322212 · Data updated 2026-11-12
This study is testing if taking thiamine can help improve brain function and mood in adults with Type 2 diabetes.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 40 Years to 65 Years |
| Sex | All |
| Enrollment | 52 (estimated) |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | August 1, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | March 31, 2027 |
| Registry record updated | March 13, 2026 |
| Trial ID | NCT06322212 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults diagnosed with Type 2 diabetes who are outpatient and can comfortably undergo MRI imaging.
✕Probably not a fit
Patients with a history of stroke, current thiamine intake, or certain neurological and psychiatric disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of thiamine (vitamin B1) treatment on brain function in adults diagnosed with Type 2 diabetes mellitus (T2DM). Participants will undergo brain MRI scans, cognitive assessments, blood tests, and questionnaires to evaluate the potential benefits of thiamine supplementation. The study aims to determine if thiamine can improve blood-brain barrier function and subsequently enhance cognitive and mood functions in T2DM patients. Participants will visit UCLA twice over a six-month period for assessments lasting approximately 2.5 to 3 hours each.
Why it matters
Potential benefit: If successful, this treatment could improve cognitive function and mood in patients with Type 2 diabetes, potentially reducing the risk of dementia.
How similar studies have gone: Pre-clinical studies have suggested that thiamine treatment may improve blood-brain barrier function, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed T2DM * Outpatient status * Able to lay flat for imaging Exclusion Criteria: * A previous history of stroke * Current in-take of thiamine * Known thiamine allergy * Seizure disorder * Head trauma * Myocardial infarction * Current pregnancy (if female) * Diagnosed neuropsychiatric disorders (clinical depression, schizophrenia, manic-depression) * Diagnosed dementia * Sleep disordered breathing * Airway or chest deformities that would interfere with breathing * Chronic obstructive pulmonary disease * Cystic fibrosis * Presence of brain mass lesions * Any history of drug abuse (e.g., cocaine, tobacco, or cannabis) * Renal failure (requiring dialysis) * All T2DM adults with metallic and electronic implants (phrenic or cardiac pacemakers; although some pacemakers and cardioverter defibrillators are safe at a low magnetic field, they are not safe at 3.0-Tesla scanner) * Non-removable insulin pump/glucose sensor * Braces * Body weight more than 300 pounds (weight and height will be used to calculate BMI to determine if the patient will fit in the scanner and stay within parameters of size restrictions of MRI scanner table) * Any other contraindications to MRI, such as claustrophobia, or metallic-based tattoos, as per MRI safety website suggestions, will also be excluded.
Where it's running
-
UCLA
Los Angeles, California, United States Recruiting
Study contacts
- Study coordinator: Rajesh Kumar, PhD
- Email: rkumar@mednet.ucla.edu
- Phone: 310-206-1699
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Technology-assisted home strength training for adults 55–80 with type 2 diabetes and mild cognitive impairment
This 12-week program will test whether a telehealth-supported home strength-training routine helps adults 55–80 with type 2 diabetes and mild cognitive impairment stick with exercise and improve strength, thinking, and blood sugar.
-
Digital Care for holistic health in older adults with diabetes and multiple conditions
This study tests a digital care program to help adults 50+ with type 2 diabetes and other chronic diseases improve disease control, self-management, mood, and quality of life.
-
Evaluating Dapagliflozin and Pioglitazone for Type 2 Diabetes Management
This study is testing if adding the medications Dapagliflozin and Pioglitazone to Metformin and a DPP-4 inhibitor can help people with Type 2 Diabetes better control their blood sugar levels.
-
Assessing the impact of geriatric evaluations on diabetes treatment for older adults
This study tests if using special evaluations for older adults can help doctors create better diabetes treatment plans for elderly patients with type 2 diabetes.
-
Improving heart health for low-income individuals with diabetes and obesity
This study is testing whether a 6-month program that includes training, exercise help, and community support can improve heart health for low-income people with diabetes and obesity compared to regular education and exercise access.
-
Increasing dietary fiber in patients with heart failure and diabetes
This study tests if adding potato starch to the diets of people with heart failure and diabetes can improve their gut health and overall well-being.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.